O enantato de PrasterOne é um sintético, injetado, ProDrugado de éster duradouro de desidroepiandosterona (DHEA), um androgênio fraco e neurosteróide. É um componente do depósito Gynodian, uma formulação combinada de 4 mg estradiol valerado e 200 mg prastrone enantato em petróleo para injeção intramuscular de depósito normalmente uma vez a cada 4 semanas, that is used in the treatment of menopausal symptoms and is marketed in Europe and South America. Prasterone enanthate has an average duration of 18 days in this formulation. The pharmacokinetics of the formulation have also been assessed in other studies. The medication was patented, by Schering, in 1971.
1. Retard aging and maintain youthful vigor
2. Enhance physical fitness, improve mood and sleep, improve memory
3. Improve sexual function, increase libido
4. Regulate the immune system function, improve the body immunity
5 weight loss
6 auxiliary treatment of diseases
